Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Silverstein

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|October 6, 2022
Precise DNA cleavage using CRISPR-SpRYgestsKathleen A Christie, Jimmy A Guo, Rachel A Silverstein, et al.
Nature Biotechnology|February 2, 2026
Customizing CRISPR-Cas PAM specificity with protein language modelsStephen Nayfach, Aadyot Bhatnagar, Andrey Novichkov, et al.
Nature Communications|October 4, 2023
PAM-flexible genome editing with an engineered chimeric Cas9Lin Zhao, Sabrina R T Koseki, Rachel A Silverstein, et al.
Nature Microbiology|January 2, 2023
Evolution of CRISPR-associated endonucleases as inferred from resurrected proteinsBorja Alonso-Lerma, Ylenia Jabalera, Sara Samperio, et al.
Nature|April 22, 2025
Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learningRachel A Silverstein, Nahye Kim, Ann-Sophie Kroell, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Mechanistic machine learning enables interpretable and generalizable prediction of prime editing outcomesAlvin Hsu, Peter J Chen, Angus H Li, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
<i>In vivo</i> Treatment of a Severe Vascular Disease via a Bespoke CRISPR-Cas9 Base EditorChristiano R R Alves, Sabyasachi Das, Vijai Krishnan, et al.
Nature Biomedical Engineering|September 11, 2025
Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in miceChristiano R R Alves, Sabyasachi Das, Vijai Krishnan, et al.
The New England Journal of Medicine|May 15, 2025
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic DiseaseKiran Musunuru, Sarah A Grandinette, Xiao Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|October 6, 2022
Precise DNA cleavage using CRISPR-SpRYgestsKathleen A Christie, Jimmy A Guo, Rachel A Silverstein, et al.
Nature Biotechnology|February 2, 2026
Customizing CRISPR-Cas PAM specificity with protein language modelsStephen Nayfach, Aadyot Bhatnagar, Andrey Novichkov, et al.
Nature Communications|October 4, 2023
PAM-flexible genome editing with an engineered chimeric Cas9Lin Zhao, Sabrina R T Koseki, Rachel A Silverstein, et al.
Nature Microbiology|January 2, 2023
Evolution of CRISPR-associated endonucleases as inferred from resurrected proteinsBorja Alonso-Lerma, Ylenia Jabalera, Sara Samperio, et al.
Nature|April 22, 2025
Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learningRachel A Silverstein, Nahye Kim, Ann-Sophie Kroell, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Mechanistic machine learning enables interpretable and generalizable prediction of prime editing outcomesAlvin Hsu, Peter J Chen, Angus H Li, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
<i>In vivo</i> Treatment of a Severe Vascular Disease via a Bespoke CRISPR-Cas9 Base EditorChristiano R R Alves, Sabyasachi Das, Vijai Krishnan, et al.
Nature Biomedical Engineering|September 11, 2025
Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in miceChristiano R R Alves, Sabyasachi Das, Vijai Krishnan, et al.
The New England Journal of Medicine|May 15, 2025
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic DiseaseKiran Musunuru, Sarah A Grandinette, Xiao Wang, et al.
Pageof 1